Brief: Cage Bio Inc. Announced R&D Agreement With Nitto Denko Corp For Transdermal Formulation Of Undisclosed Molecules
July 7 (Reuters) - CAGE BIO INC.:
* CAGE BIO INC. - ANNOUNCED RESEARCH AND DEVELOPMENT
AGREEMENT
WITH NITTO DENKO CORPORATION FOR TRANSDERMAL FORMULATION OF
UNDISCLOSED MOLECULES
Source text for Eikon: ID:nPn20dYgca
Further company coverage: 6988.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NITTO DENKO
See all newsBrief: Hemogenyx Pharmaceuticals Enters Feasibility Study Agreement With Nitto Denko
Brief: Nitto Denko Corporation - To Retire Treasury Shares Worth 2.28% Of Outstanding Stock On Oct 20
Table: Nitto Denko -Q1 group results (IFRS)
Table: Nitto Denko -2025/26 parent results
Table: Nitto Denko -2025/26 group results (IFRS)